This forms the basis why new drug candidates, such as natural polyphenols, which prevent IL-1β secretion by inhibiting the function of NLRP3 or other inflammasome components, have lately been under scrutiny in relation to immunological, neurological, and metabolic diseases [37,38]. The gene discussed is NLRP3; the disease is Other metabolic disease.